toripalimab
junshi biosciences,coherus
['neotorch', 'toripalimab', 'lung', 'nsclc', 'sclc', 'lcsm,(-blcsm)']
perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage ii/ill non-small cell lung cancer (nsclc):
interim event-free survival (efs) analysis of p the phase iii neotorch study. #asco23 #lcsm 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm